Prospective evaluation of minimal residual disease in acute myeloid leukemia using TIM-3 as a leukemia marker
Not Applicable
- Conditions
- acute myeloid leukemia
- Registration Number
- JPRN-UMIN000030977
- Lead Sponsor
- Department of Medicine and Biosystemic Sciences, Kyushu University Graduate School of Medicine
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
(1) Refractory or relapsed acute myeloid leukemia patients (2)Secondary AML patients (3)Acute promyelocytic leukemia patients (4) A patient whom the researchers decide as an inappropriate case
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The correlation between the prognosis of acute myeloid leukemia and the TIM-3-expressing residual leukemic stem cells
- Secondary Outcome Measures
Name Time Method